isoxazoles has been researched along with way-362450 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Li, WH; Liu, GX; Tang, Y; Zheng, MY | 1 |
| Alawad, AS; Levy, C | 1 |
| Chow, MD; Guo, GL; Lee, YH | 1 |
3 review(s) available for isoxazoles and way-362450
| Article | Year |
|---|---|
[Progress in the ligands and their complex structures of farnesoid X receptor].
Topics: Animals; Anticholesteremic Agents; Azepines; Benzene Derivatives; Chenodeoxycholic Acid; Crystallization; Humans; Indoles; Isoxazoles; Ligands; Molecular Structure; Multienzyme Complexes; Pregnenediones; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship | 2012 |
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2016 |
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Topics: Azepines; Bile Acids and Salts; Carcinoma, Hepatocellular; Disease Progression; Energy Metabolism; Gene Expression Regulation; Glucose; Humans; Indoles; Isoxazoles; Liver; Liver Cirrhosis; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Receptors, Steroid | 2017 |